On April 12, 2024, Clover Biopharmaceuticals, Ltd closed the transaction. The transaction included participation from 10 investors, which includes a single non-accredited investor.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.46 HKD | +3.37% | +14.10% | -28.23% |
04-12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
04-08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.23% | 73.88M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding